Cite
MLA Citation
A Berberich et al.. “P11.07 LAPTM5 functions as a tumor suppressor via CD40 - NFêB pathway inhibition and represents a potential biomarker for temozolomide sensitivity in CD40 proficient glioblastoma.” Neuro-oncology, vol. 21, n.d., p. iii43. http://access.bl.uk/ark:/81055/vdc_100109734318.0x00000c